| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3400 | 112-80-1 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| CHEBI has role | CHEBI:22586 | antioxidants |
| CHEBI has role | CHEBI:46787 | solvents |
| CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
| CHEBI has role | CHEBI:76924 | plant metabolites |
| CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
| CHEBI has role | CHEBI:78444 | Alpha-carboxylesterase inhibitor |
| CHEBI has role | CHEBI:83038 | Daphnia galeata metabolites |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Sensation Disturbance of Genitals | contraindication |
| Species | Use | Relation |
|---|---|---|
| Horses | Stimulates infiltration of cellular blood components that subsequently differentiate into fibrous and/or fibrocartilaginous tissue | Indication |
| Product | Applicant | Ingredients |
|---|---|---|
| Osteum Solution 50 mg | Summit Hill Laboratories | 1 |
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 4.76 | acidic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Fatty-acid amide hydrolase 1 | Enzyme | Ki | 5.22 | CHEMBL | |||||
| Aromatase | Enzyme | IC50 | 4.49 | CHEMBL | |||||
| Peroxisome proliferator-activated receptor alpha | Nuclear hormone receptor | IC50 | 6.22 | CHEMBL | |||||
| Peroxisome proliferator-activated receptor gamma | Nuclear hormone receptor | IC50 | 5.39 | CHEMBL | |||||
| Tyrosine-protein phosphatase non-receptor type 1 | Enzyme | IC50 | 5.21 | CHEMBL | |||||
| Fatty acid-binding protein, adipocyte | Cytosolic other | Ki | 6.73 | CHEMBL | |||||
| DNA topoisomerase 1 | Enzyme | IC50 | 4.51 | CHEMBL | |||||
| Telomerase reverse transcriptase | Enzyme | IC50 | 5.07 | CHEMBL | |||||
| Fatty acid-binding protein, epidermal | Cytosolic other | Ki | 6.61 | CHEMBL | |||||
| Peroxisome proliferator-activated receptor delta | Nuclear hormone receptor | IC50 | 5.28 | CHEMBL | |||||
| Free fatty acid receptor 1 | GPCR | AGONIST | EC50 | 5.70 | IUPHAR | ||||
| Fatty acid-binding protein, liver | Unclassified | Kd | 6.70 | CHEMBL | |||||
| Tissue factor | Membrane receptor | IC50 | 4.10 | CHEMBL | |||||
| Free fatty acid receptor 4 | GPCR | AGONIST | EC50 | 4.70 | IUPHAR | ||||
| Nuclear receptor subfamily 4 group A member 2 | Nuclear other | Kd | 4.30 | CHEMBL | |||||
| Fatty acid-binding protein, liver | Unclassified | Ki | 6.74 | CHEMBL | |||||
| Seed linoleate 13S-lipoxygenase-1 | Enzyme | Ki | 4.66 | CHEMBL |
| ID | Source |
|---|---|
| 4020299 | VUID |
| N0000148167 | NUI |
| 4020299 | VANDF |
| C0028928 | UMLSCUI |
| CHEBI:16196 | CHEBI |
| OLA | PDB_CHEM_ID |
| CHEMBL8659 | ChEMBL_ID |
| DB04224 | DRUGBANK_ID |
| D019301 | MESH_DESCRIPTOR_UI |
| 445639 | PUBCHEM_CID |
| 1054 | IUPHAR_LIGAND_ID |
| 2UMI9U37CP | UNII |
| 70616 | RXNORM |
| NOCODE | MMSL |
| 002530 | NDDF |
| 259579007 | SNOMEDCT_US |
| 427281002 | SNOMEDCT_US |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Sha-lem | HUMAN OTC DRUG LABEL | 5 | 59862-100 | OINTMENT | 14.50 g | TOPICAL | unapproved drug other | 10 sections |